NCT07104149
- Conditions
- ECOG Score of 0-1, Expected Survival Time >6 Months, Female, Age ≥ 18 Years Old, +6 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
Clinical trial condition
Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion
Explore clinical trials studying Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study
Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion trial results
Related conditions
- ECOG Score of 0-1 (1)
- Expected Survival Time >6 Months (1)
- Female, Age ≥ 18 Years Old (1)
- Locally Advanced Cervical Cancer (1)
- No Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy (1)
- Subjects Should Take Contraceptive Measures (1)
- Sufficient Organ Function (1)
- The Result of the Urine or Serum Pregnancy Test for the Subject is Negative (1)